Aldevron
Michael Chambers is the Founding CEO of Aldevron, a position held since 1998, where significant contributions have been made to the biotechnology field. In addition to this role, Michael Chambers has served as a Member of the Board of Directors at Sarepta Therapeutics since June 2022. Michael Chambers earned a Bachelor of Science degree in Biotechnology, Microbiology, and Chemistry from North Dakota State University between 1993 and 1997.
This person is not in any teams
This person is not in any offices